Apeiron RIA’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Apeiron RIA’s Portfolio EEM Stock Details EEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,145	Closed	-$315K	–	185
2022 Q3	$315K	Buy	+9,145	New	+$357K	0.15%	119
2022 Q2	–	Sell	-8,756	Closed	-$393K	–	156
2022 Q1	$393K	Buy	+8,756	New	+$413K	0.19%	96

Other funds holding EEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Apeiron RIA's EEM Position: Q4 2022 in Review

Apeiron RIA sold out of iShares MSCI Emerging Markets ETF (EEM) in Q4 2022, closing a stake of 9,145 shares — an estimated $315K sold.

Apeiron RIA first reported a position in EEM in Q1 2022 and held it in 2 quarters. The position peaked at $393K in Q1 2022. 1,318 funds tracked by Wall St. Rank hold EEM as of Q4 2022.

Apeiron RIA reported no remaining iShares MSCI Emerging Markets ETF position as of Q4 2022 after selling out during the quarter.
Apeiron RIA sold 9,145 iShares MSCI Emerging Markets ETF shares in Q4 2022, an estimated $315K.
Apeiron RIA first reported a position in iShares MSCI Emerging Markets ETF in Q1 2022 and held it in 2 quarters.
Apeiron RIA's iShares MSCI Emerging Markets ETF position peaked at $393K in Q1 2022.
1,318 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q4 2022.

Based on Apeiron RIA's 13F filing for Q4 2022, filed 20 Jan 2023.